Bo Xu

4.0k citations
147 papers · 3.0k indexed · 1 hit paper · h-index 30

Impact in

Papers in

Bo Xu

141 papers receiving 2.9k citations

Hit Papers

Programmed Targeting Pyruvate Metabolism Therapy Amplified Single‐Atom Nanozyme‐Activated Pyroptosis for Immunotherapy 2024 · 69 citations
69202420262025204060

Peers

Bo Xu
Comparison fields: 5 of 131
  • Health, Toxicology and Mutagenesis 362
  • Endocrine and Autonomic Systems 149
  • Hepatology 148
  • Immunology 391
  • Cancer Research 270
Replace Qi Cheng with:
Qi Cheng China
Liming Chen China
Jie Liu China
Shaw‐Fang Yet Taiwan
Zemin Wang United States
Su Liu China
Richard Siow United Kingdom
Venkatesh Krishnan United States
Gillian A. Gray United Kingdom
Noriko Nishimura Japan
Bo Xu relative to Qi Cheng China Qi Cheng's profile →
Citations per field
00.5×1.5×2.2×
Qi Cheng · 1×
Citations per year

Countries citing papers authored by Bo Xu

Since Specialization
Citations

This map shows the geographic impact of Bo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Xu more than expected).

Fields of papers citing papers by Bo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Xu. The network helps show where Bo Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Bo Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bo Xu Line = papers co-authored together Bo Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 202422
4 20241
5 20242
6 20248
7 202219
8 202111
9 202039
10
Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling
20193
11 201917
12 201841
13 201793
14 201546
15 201318
16
Effect observation of Bitong power fumigation combining dirigation on patients with flexor tendon injuries in area II after late-stage restoration
20131
17 201316
18 201163
19
Study on Antioxidant Activity and Constituents of Radix Paeonia veitchii
20073
20 200426

About Bo Xu

Bo Xu is a scholar working on Nephrology, Endocrine and Autonomic Systems, Cancer Research, Health, Toxicology and Mutagenesis and Surgery, having authored 147 papers that have together received 3.0k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (10 papers), Heart Rate Variability and Autonomic Control (8 papers), Neuroscience of respiration and sleep (8 papers), Birth, Development, and Health (7 papers), Lung Cancer Treatments and Mutations (6 papers), Renal Diseases and Glomerulopathies (5 papers), Reproductive Biology and Fertility (5 papers) and Advanced Nanomaterials in Catalysis (5 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (362 citations), Endocrine and Autonomic Systems (149 citations), Hepatology (148 citations), Immunology (391 citations) and Cancer Research (270 citations). Bo Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Martha K. Cathcart, Kaushik P. Patel, Yankai Xia, Gerald M. Feldman, Minjian Chen, Xinru Wang, Hong Zheng, Ashis Bhattacharjee, Xuefei Liu and Biswajit Roy. Their work appears in journals such as Scientific Reports, BMC Nephrology, Nanoscale, BMC Cancer and The Science of The Total Environment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026